{"title":"癌症患者的分子亚型","authors":"L. Navsaria, Fatema Ali, R. Goswamy","doi":"10.12816/0047462","DOIUrl":null,"url":null,"abstract":"Result: Eighty-nine patients were included in the study. A total of one hundred and two patients were diagnosed with breast cancer based on biopsy results; thirteen patients were excluded due to the unknown stage and/or grade. The mean age was 53.9 years. The majority of cases were infiltrating ductal carcinoma (IDC), 82 (92%). The most common molecular subtype detected in the study was Luminal B (ER+, PR+, HER2+), 29 (32.6%) of the study population. Nine (10%) had an unknown grade, and 8 (8.9%) had unknown stage were excluded from the analysis.","PeriodicalId":0,"journal":{"name":"","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Molecular Subtypes among Patients with Breast Cancer\",\"authors\":\"L. Navsaria, Fatema Ali, R. Goswamy\",\"doi\":\"10.12816/0047462\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Result: Eighty-nine patients were included in the study. A total of one hundred and two patients were diagnosed with breast cancer based on biopsy results; thirteen patients were excluded due to the unknown stage and/or grade. The mean age was 53.9 years. The majority of cases were infiltrating ductal carcinoma (IDC), 82 (92%). The most common molecular subtype detected in the study was Luminal B (ER+, PR+, HER2+), 29 (32.6%) of the study population. Nine (10%) had an unknown grade, and 8 (8.9%) had unknown stage were excluded from the analysis.\",\"PeriodicalId\":0,\"journal\":{\"name\":\"\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0,\"publicationDate\":\"2018-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.12816/0047462\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12816/0047462","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Molecular Subtypes among Patients with Breast Cancer
Result: Eighty-nine patients were included in the study. A total of one hundred and two patients were diagnosed with breast cancer based on biopsy results; thirteen patients were excluded due to the unknown stage and/or grade. The mean age was 53.9 years. The majority of cases were infiltrating ductal carcinoma (IDC), 82 (92%). The most common molecular subtype detected in the study was Luminal B (ER+, PR+, HER2+), 29 (32.6%) of the study population. Nine (10%) had an unknown grade, and 8 (8.9%) had unknown stage were excluded from the analysis.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
